share_log

Bee Vectoring Technologies to Explore Partnership Opportunities at ABIM 2023, the Top Conference for the Ag Biologicals Industry

Bee Vectoring Technologies to Explore Partnership Opportunities at ABIM 2023, the Top Conference for the Ag Biologicals Industry

Bee Vectoring Technologies將在農業生物製品行業的頂級會議ABIM 2023上探索合作機會
newsfile ·  2023/10/24 20:00

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - October 24, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE) (the "Company" or "BVT") is pleased to announce that it will be exploring various partnership opportunities through nine confirmed meetings with industry players and potential partners at ABIM 2023 (Annual Biocontrol Industry Meeting), an internationally-recognized global meeting place to do business and network within the industry. The conference runs October 23 to 25 in Basil, Switzerland and is co-organized by the Research Institute of Organic Agriculture (FiBL) and the International Biocontrol Manufacturers Association (IBMA).

安大略省密西索加和加利福尼亞州薩克拉門託-(新聞檔案公司-2023年10月24日)-BEE Vectoring Technologies International Inc.(CSE:BEE)(OTCQB:BEVVF)(CVE:BEE)(“公司”或“BVT”)很高興地宣佈,將在ABIM 2023(生物控制行業年度會議)上與行業參與者和潛在合作夥伴舉行9次確認的會議,探索各種合作夥伴機會。ABIM 2023是國際公認的在行業內開展業務和建立網路的全球會議場所。這次會議於10月23日至25日在瑞士巴茲爾舉行,由有機農業研究所(FiBL)和國際生物控制製造商協會(IBMA)聯合舉辦。

At this year's ABIM, an estimated 1,700 participants from more than 50 nations will network face-to-face, listen to inspiring panel discussions, and see exciting presentations on the latest innovations. SMEs and large enterprises are well-represented, with delegates and the 100+ exhibitors meeting throughout the event.

在今年的ABIM上,估計有來自50多個國家的1700名與會者將面對面地交流,聽取鼓舞人心的小組討論,並觀看關於最新創新的令人興奮的演講。中小企業和大型企業都有很好的代表,代表和100多家參展商在整個活動中都參加了會議。

"The ABIM is an incredible chance for innovators like BVT to connect with the industry's biggest and most important players and I'm pleased to be back at this premiere annual event," said Ashish Malik, CEO of BVT. "There are so many opportunities here with existing and potential partners to progress BVT's ongoing expansion strategy. In addition to our confirmed meetings, there are always several unplanned meetings that develop from informal conversations, so this is a great way to update the industry at-large on our progress."

BVT首席執行官阿希什·馬利克表示:“對於像BVT這樣的創新者來說,ABIM是一個與業內最大、最重要的參與者建立聯繫的令人難以置信的機會,我很高興再次參加這個首屈一指的年度活動。”與現有和潛在的合作夥伴在這裡有如此多的機會來推進BVT正在進行的擴張戰略。除了我們確認的會議之外,總是有幾次計劃外的會議是從非正式對話中發展出來的,所以這是一個很好的方式來向整個行業通報我們的進展情況。

"ABIM is an event that's helping us all work together to facilitate the transformation to sustainable agriculture," said Christoph Lehnen, BVT Business Manager for Europe, Africa and Middle East. "At the event, we plan to identify and further develop new markets, channels and product applications for BVT's proprietary natural precision agriculture system."

BVT歐洲、非洲和中東業務經理Christoph Lehnen表示:“ABIM是一個幫助我們所有人共同努力,促進向可持續農業轉型的活動。”在此次活動中,我們計劃為BVT專有的天然精準農業系統確定並進一步開發新的市場、渠道和產品應用。

About Bee Vectoring Technologies International Inc.
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides - and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 55 granted patents, many more patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.

關於蜜蜂向量化技術國際公司。
BVT是一家農業技術公司,在2400億美元的作物保護和化肥市場上具有巨大的全球市場機會,是市場顛覆者。BVT開創了一種天然精準農業系統,通過使用商業培育的蜜蜂為作物提供生物農藥替代品,取代了化學農藥和浪費的植物保護產品噴霧應用。BVT的獲獎技術精密向量化對蜜蜂完全無害,允許微量的天然衍生殺蟲劑(稱為生物製品)直接輸送到花朵中,提供比傳統化學殺蟲劑更好的作物保護和產量結果-並改善土壤、微生物群和環境的健康。目前,BVT擁有超過55項已授予的專利,還有更多的專利在全球所有主要農業國家懸而未決,並已將其Vectorite在美國環保局CR-7註冊(環保局註冊號90641-2),作為註冊生物殺菌劑出售,用於標籤作物。

Additional information can be viewed at the Company's website . To receive regular news updates from the Company, subscribe at .

欲瞭解更多資訊,請訪問公司網站。要定期接收公司的最新新聞,請訂閱。

BVT Company Contact:
Ashish Malik, President & CEO, BVT
info@beevt.com

BVT公司聯繫人:
阿什什·馬利克,總裁,BVT首席執行官
郵箱:info@beevt.com

BVT Investor Contacts:
Babak Pedram
Virtus Advisory Group
Tel: 416-646-6779
bpedram@virtusadvisory.com

BVT投資者聯繫人:
巴布克·佩德拉姆
Virtus顧問團
電話:416-646-6779
郵箱:bpedram@virtusvisory.com

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, "annual revenue potential", are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company's Filing Statement dated August 14,2020, filed with the CSE and securities regulatory authorities in certain provinces of Canada and available at . Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.

CSE既沒有批准也沒有反對本新聞稿的內容。CSE不對本新聞稿的充分性或準確性承擔責任。本新聞稿中包含的某些陳述構成“前瞻性資訊”,這一術語在適用的加拿大證券法中有定義。“可能”、“應該”、“潛在”、“將”、“尋求”、“打算”、“計劃”、“預期”、“相信”、“估計”、“預期”以及與公司有關的類似表述“年度收入潛力”,旨在識別前瞻性資訊。除歷史事實以外的所有陳述都可能是前瞻性資訊。此類陳述反映了公司目前對未來事件的看法和意圖,以及公司目前掌握的資訊,受某些風險、不確定因素和假設的影響,這些風險、不確定因素和假設包括:種植面積、有競爭力的化學殺蟲劑的銷售價格以及美元對加拿大元的匯率。在提供前瞻性資訊時採用了重大因素或假設。如果這些風險或不確定性中的一個或多個成為現實,許多因素可能會導致這些前瞻性資訊可能表達或暗示的實際結果、業績或成就與本文描述的結果、業績或成就不同。這些因素包括法律的變化、競爭、訴訟、實施商業戰略和尋求商業機會的能力、資本市場的狀況、開展業務的資金和資源的可獲得性、新技術、保護知識產權的能力、獲得產品專利保護的能力、第三方知識產權侵權索賠、影響產品的監管變化、研發活動失敗、達到和維持盈利的能力、對商業和技術專家的依賴、有效管理業務運營和增長的能力、債務發行、現有證券的稀釋、上市證券的波動性、潛在的利益衝突、不可能支付股息。為第三方知識產權侵權索賠辯護的潛在成本、確保與製造商和採購商的關係的能力、一般經濟、市場和商業條件,以及公司於2020年8月14日提交給加拿大某些省份的CSE和證券監管機構的備案聲明中討論或提到的風險因素,可在上查閱。如果任何因素以意想不到的方式影響公司,或者前瞻性資訊背後的假設被證明是不正確的,實際結果或事件可能與預測的結果或事件大不相同。任何此類前瞻性資訊都明確地受到本警示聲明的限制。此外,公司不對此類前瞻性資訊的準確性或完整性承擔責任。本新聞稿中包含的前瞻性資訊是截至本新聞稿發佈之日的資訊,除適用法律要求外,公司沒有義務公開更新或修改任何前瞻性資訊。所有數位都是以加元計算的。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論